News for Read Beyond News
People with high blood pressure may wonder if medication is necessary to bring the number down. But the lifestyle of the people also plays an important role in treating high blood pressure. Controlling high blood pressure with a healthy lifestyle might delay, prevent, or reduce the need for medication. There
Read More
According to many doctors and dieticians, there are several natural ways to lose weight. A proper diet and a little bit of exercise can help people lose weight. Some of the ways to lose weight include, adding protein to the diet. The body burns calories while metabolizing and digesting the
Read More
Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., launched Leuprolide Acetate Injection Depot 22.5 mg. The injection was approved by the US Food and Drug Administration based on a New Drug Application (NDA) submitted under the regulatory pathway 505(b)(2). According to Cipla, Leuprolide Acetate Injection Depot contains 22.5 mg
Read More
CSL, a global biotechnology leader announced that the US Food and Drug Administration (FDA) approved HEMGENIX, the first one-time gene therapy to treat patients with hemophilia B. HEMGENIX is used to treat adults with hemophilia B who currently use factor IX prophylaxis therapy or have life-threatening haemorrhages. In the clinical trial,
Read More
The US Food and Drug Administration (FDA) has approved the use of Provention Bio’s drug teplizumab in those aged eight years and older, said Povention Bio. According to Provention Bio, the first treatment aimed at delaying the onset of type-1 diabetes dependent on insulin. The US FDA has allowed teplizumab, to
Read More
World Health Organization (WHO), and the United States Agency for International Development (USAID) have provided 2 million dollars of medical equipment and supplies to fight against COVID-19 and several other diseases. The commodities, include protective and medical equipment, test kits, medication, oxygen supplies, laptops, and tablets. The supplies are part
Read More
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Beyfortus (nirsevimab) to treat respiratory syncytial virus (RSV) lower respiratory tract disease in the infants and newborns during their first RSV season. This approval come after the European Commission approve Beyfortus earlier this month. According to studies, about 90 percent
Read More
The United States will keep the COVID-19 Public Health Emergency status of the pandemic in place, allowing millions of US citizens to get free COVID-19 tests, treatments, and vaccines until April 2023, say US government officials. The US population may be in the middle of a COVID-19 surge in January 2023,
Read More
After losing the approval for emergency use of COVID-19 vaccines, AstraZeneca has finally stopped efforts to sell its COVID-19 vaccine shots in the United States. AstraZeneca has now decided to withdraw its application for the COVID-19 vaccine Vaxzevria with the US FDA, said CEO Pascal Soriot during a press briefing. Because
Read More
Oncopeptides AB, a biotech company focused on R&D of development of therapies to treat haematological diseases, announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization for Pepaxti in combination with dexamethasone in the United Kingdom. The approval of Pepaxti in the United Kingdom is an
Read More